The Centers for Medicare & Medicaid Services is preparing to cover CBD under Medicare, while Senate Republicans are attempting to block Washington, D.C. from legalizing recreational cannabis sales. Meanwhile, Democratic lawmakers are planning to reverse the federal recriminalization of hemp THC products, and the Cato Institute has filed a brief urging the U.S. Supreme Court to consider a challenge to federal marijuana prohibition.

Feds Plan Medicare Coverage for CBD Products

Nov 28, 2025

Source:

Tom Angell

Marijuana Moment

The federal government is finally moving toward legitimizing plant medicine, with Medicare preparing to cover CBD for the first time. This is a massive win for patients who rely on cannabinoids for relief but have long been forced to pay entirely out of pocket. While the feds are opening one door, others remain stuck; Senate Republicans are still trying to block D.C. from launching a legal recreational market, and the fight over hemp-derived THC products continues to heat up as lawmakers scramble to reverse recent bans. Meanwhile, the Supreme Court is being urged to hear a challenge against federal marijuana prohibition itself.

For the average toker, these headlines show that the walls of prohibition are crumbling, even if some politicians are still trying to patch the cracks. Medicare coverage is a huge step toward treating cannabis like the medicine it is, rather than a criminal substance. These shifts in federal policy and legal challenges mean we’re closer than ever to a world where access is a right, not a legal gamble. Keep your eyes on the courts—the next few months could be historic.